No Data
Xiangyu Medical (688626.SH): has repurchased a total of 3.0000% of the company's shares.
On December 27th, Gelonghui reported that Xiangyu Medical (688626.SH) announced that, in light of the previous two share repurchase plans, as of December 27, 2024, the company's dedicated repurchase securities Account has cumulatively repurchased 4,800,000 shares through centralized bidding transactions, accounting for 3.0000% of the company's total share capital of 160,000,000 shares, of which 4,380,000 shares were repurchased during the implementation period of the company's first two repurchase plans.
Xiangyu Medical Appoints Chair
Xiangyu Medical (688626.SH): Key technical staff member Ma Denwei has left.
Xiangyu Medical (688626.SH) announced that the company's core technician, Ma Denwei, has resigned from the company for personal reasons...
Xiángyǔ Medical (688626.SH): He Yongzheng was elected as Director.
Gelonghui reported on December 19 that Xiangyu Medical (688626.SH) announced that Mr. He Yongzheng was elected as the chairman of the company's third Board of Directors, with his term starting from the date of this Board of Directors' approval until the end of the third Board of Directors' term.
Xiangyu Medical (688626.SH): "Asia Vets Rehabilitation Equipment (Southwest) Sales Center Project" concludes.
Gelonghui reported on December 19 that Xiangyu Medical (688626.SH) held the first meeting of the third Board of Directors and the first meeting of the third Supervisory Board on December 19, 2024. They reviewed and approved the proposal regarding the completion of the company's fundraising projects and the permanent replenishment of working capital with the remaining funds after the completion of all fundraising projects. The company agreed to conclude the fundraising project "Asia Vets Rehabilitation Equipment (Southwest) Marketing Center Project" and the total remaining raised funds of 36.1245 million yuan (after deducting handling fees) from the conclusion of the five fundraising projects in the initial public offering.
Xiangyu Medical (688626.SH): Suzhou Jifeng, Fuzhou Jifeng, and their concerted actors are no longer shareholders holding more than 5% of the company.
On December 17, 2024, Triumphant Medical (688626.SH) announced that it received a "Simplified Equity Change Report" from Suzhou Jifeng, Fuzhou Jifeng, and Jiaxing Jifeng No. 1. From December 9 to December 16, 2024, Suzhou Jifeng and Fuzhou Jifeng reduced their shareholdings in the company through centralized bidding trading, totaling 400,200 shares, accounting for 0.250125% of the company's total share capital. After this equity change, Suzhou Jifeng, Fuzhou Jifeng, and their concerted action party Jiaxing Jifeng No. 1 together hold 7,999,920 shares of the company.
Investors Aren't Buying Xiangyu Medical Co.,Ltd's (SHSE:688626) Earnings
